Sequence by WeightWatchers review: is it worth it?
Sequence (acquired by WeightWatchers) connects members with clinicians prescribing GLP-1 and other weight loss medications.
A credible GLP-1 telehealth program with a strong behavioral backbone
Sequence, rebranded as WeightWatchers Clinic and offered through the Med+ membership, is one of the more established and clinically grounded GLP-1 telehealth services. Its real value is combining brand-name prescriptions with insurance coordination and WeightWatchers' decades-old behavioral and nutrition program. The big catch: membership is relatively cheap, but the medication itself often is not, and coverage is far from guaranteed.
Check PriceFrom $99/mo
Pros
- ✓Prescribes brand-name, FDA-approved medications (Wegovy, Zepbound, Saxenda) rather than relying on the unregulated compounded versions the FDA has warned about
- ✓Pairs prescriptions with WeightWatchers' established behavioral program, dietitian access, and a GLP-1-specific Success Program aimed at preserving muscle
- ✓Backed by peer-reviewed real-world data (Ard et al., 2024, Obesity) showing roughly 19% average 12-month weight loss among program completers, broadly in line with the underlying drug trials
- ✓Handles insurance coordination and prior authorizations for you, which can meaningfully reduce medication cost when coverage exists
- ✓Relatively low membership entry cost with board-certified clinician oversight and ongoing monitoring
Cons
- ✕Medication is billed separately and can list near or above $1,000/month without coverage, so the cheap membership price alone is misleading
- ✕Insurance coverage for GLP-1s for weight loss is inconsistent and frequently denied, leaving many patients self-paying
- ✕Weight regain is common after stopping the medication, and access ends if you cancel membership or lose coverage
- ✕The lowest membership pricing typically requires a 12-month commitment
- ✕Care is fully remote, which may not suit people who want in-person exams or who have complex medical needs
- ✕Published program weight-loss averages reflect patients who completed 12 months, a minority of those who started, so typical results in the broader population are likely lower
How it works
Sequence is a telehealth platform, not a drug. You complete an online health-history questionnaire, then have a video visit with a board-certified clinician who decides whether a prescription weight-loss medication is safe and appropriate for you. The medications prescribed are mostly GLP-1 (and dual GLP-1/GIP) receptor agonists such as semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda); non-GLP-1 options like metformin or naltrexone/bupropion may also be used when appropriate. These drugs mimic gut hormones that slow stomach emptying, blunt appetite, and increase fullness, so many people eat less without constant hunger. Layered on top is WeightWatchers' behavioral program: the Points food system, dietitian access, fitness guidance, and a GLP-1 Success Program focused on protein intake and muscle preservation during weight loss.
Active ingredient: Brand-name GLP-1
Effectiveness
Real-world and trial evidence for these medications is genuinely strong, though the platform-specific figures should be read with caution. A 2024 retrospective analysis in the journal Obesity (Ard et al.) of the WeightWatchers/Sequence telehealth program reported that, among patients with complete data at 12 months, average weight loss was about 19.4% of initial body weight, with roughly 21.2% on tirzepatide and the semaglutide formulations (Wegovy and Ozempic) in the mid-teens, broadly 13 to 15 percent. A key caveat: of the 53,590 patients who started treatment, only about 6,089 had complete 12-month data, so these completer averages likely overstate typical results because people who stopped early or regained are underrepresented. These outcomes are broadly in line with the pivotal drug trials: semaglutide 2.4 mg produced about 14.9% mean weight loss over 68 weeks in STEP 1 (NEJM 2021); tirzepatide produced roughly 20.9% (15 mg, treatment-regimen estimand) and up to about 22.5% over 72 weeks in SURMOUNT-1 (NEJM 2022); and in the head-to-head SURMOUNT-5 trial (NEJM 2025) tirzepatide outperformed semaglutide, about 20.2% versus 13.7% at 72 weeks. Individual results vary widely and depend heavily on staying on the medication and engaging with the program.
Side effects
The most common side effects come from the medications, not the platform, and are mostly gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort, usually worst when starting or increasing the dose and often easing over time. Slow dose titration and dietary adjustments can help. Less common but serious risks include an FDA boxed warning for thyroid C-cell tumors (based on rodent studies; human risk is not established), along with reported cases of pancreatitis, gallbladder disease and gallstones, kidney injury from dehydration, and, with tirzepatide, possible reduced absorption of oral contraceptives. Rapid weight loss can also cause loss of muscle mass, which the WW GLP-1 Success Program tries to counter with high-protein and strength guidance. Seek prompt medical attention for severe or persistent abdominal pain, persistent vomiting, or signs of an allergic reaction, and report concerning symptoms to your care team. This is not a complete list of side effects.
Cost
Starts at $99/mo from Sequence (WeightWatchers).
As of 2026, WW Clinic / Med+ membership is commonly advertised at about $25/month for the first two to three months, then roughly $74/month for the remainder of a 12-month plan, with month-to-month options reported around $149/month. Membership covers clinician visits, insurance coordination, labs, coaching, and the WW app, but the medication is billed separately. List prices for brand-name GLP-1s can run roughly $1,000 to $1,350 per month, but few people pay that: WeightWatchers and the manufacturers offer cash-pay programs that are far lower (for example, Novo Nordisk's self-pay Wegovy oral tablet has been offered near $149/month and WW has advertised cash-pay injectable starter pricing well under list), and commercial insurance, where it covers weight-loss GLP-1s, can drop out-of-pocket costs to roughly $25 to $150/month. Coverage and savings eligibility vary widely, so verify your specific plan and compare WW's drug pricing against pharmacy and manufacturer options before committing.
Is it worth it?
If you qualify medically and want a structured program rather than a bare prescription, WW Clinic / Med+ is a solid, reasonably transparent choice with genuine clinical oversight and the WeightWatchers behavioral system behind it. Just budget for the medication separately, push hard on insurance coordination, compare WW's cash-pay drug pricing against pharmacy and manufacturer options, and understand you can lose access to the drug the moment you stop paying or your coverage lapses. Decisions about starting, changing, or stopping any medication should be made with your prescribing clinician.
Frequently asked questions
Is Sequence the same as WeightWatchers Clinic?
Yes. WeightWatchers acquired the telehealth company Sequence in 2023 in a deal valued at about $132 million and rebranded it as WW Clinic, now offered through the Med+ membership. It is the same GLP-1 prescribing service operating under the WeightWatchers name.
How much does Sequence / WeightWatchers Clinic cost in 2026?
Membership is commonly about $25/month for the first two to three months, then roughly $74/month for the rest of a 12-month plan, with month-to-month options around $149/month. The medication is billed separately. Brand-name GLP-1s can list around $1,000 to $1,350/month, but cash-pay programs from WeightWatchers and the manufacturers, and insurance where it applies, are often far cheaper.
What medications can WeightWatchers Clinic prescribe?
Clinicians can prescribe FDA-approved GLP-1 medications including semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda), an oral semaglutide option, and non-GLP-1 drugs such as metformin or naltrexone/bupropion when appropriate. The clinician decides what is suitable based on your health history; not everyone is eligible.
Does insurance cover WeightWatchers GLP-1 medication?
Sometimes. WW Clinic coordinates with your insurer and handles prior authorizations, but coverage for GLP-1 drugs used for weight loss is inconsistent and often denied. If your plan covers the drug, out-of-pocket cost can fall to roughly $25 to $150/month; if not, you may pay a cash-pay price, which WeightWatchers and the manufacturers often set well below list. Verify your specific plan before committing.
How much weight can you lose with WeightWatchers Clinic?
A 2024 study in the journal Obesity (Ard et al.) of the WeightWatchers/Sequence platform found about 19.4% average body-weight loss at 12 months among patients with complete data, with roughly 21.2% on tirzepatide and the semaglutide formulations in the mid-teens. Because only a minority of patients had complete 12-month data, these are completer averages and likely overstate typical results. Individual outcomes vary and depend on staying on treatment and engaging with the program.
Who should not use the WeightWatchers GLP-1 program?
GLP-1 medications should be avoided if you have a personal or family history of medullary thyroid cancer (MTC) or MEN2 syndrome, are pregnant or planning pregnancy, or have had a serious allergic reaction to the drug. People with a history of pancreatitis, gallbladder disease, gastroparesis, or significant kidney problems need careful clinician evaluation. A licensed clinician makes the final decision based on your full history.
What are the side effects of the medications prescribed?
The most common are gastrointestinal: nausea, vomiting, diarrhea, and constipation, usually worst when starting or increasing the dose and often improving over time. Less common but serious risks include pancreatitis, gallbladder problems, kidney injury from dehydration, and a boxed warning for thyroid C-cell tumors based on animal data. Muscle loss during rapid weight loss is also a concern. This is not a complete list; report severe or persistent symptoms to your care team.
What happens if you stop the medication?
Weight regain is common after stopping GLP-1 medications because appetite tends to return toward baseline. Access to the prescription also ends if you cancel your WW membership or lose insurance coverage. For many people these drugs are used as a long-term treatment rather than a short course, but any decision to stop should be made with your clinician.
Is WeightWatchers Clinic legit and safe?
It is a legitimate US telehealth service that uses board-certified clinicians to prescribe FDA-approved medications and has published real-world outcome data. As with any GLP-1 program, the main concerns are cost transparency around the separately billed medication, the inherent side effects of these drugs, and the limits of fully remote care, rather than the platform's legitimacy. Safety depends on appropriate clinical screening and monitoring.
Sources
- Twelve-month analysis of real-world evidence from a telehealth obesity-treatment provider using antiobesity medications — Obesity (Silver Spring), Wiley — Ard et al. (2024)
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — The New England Journal of Medicine (2025)
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — The New England Journal of Medicine (2021)
- Medical Weight-Loss Clinic Pricing & Plans (WeightWatchers Clinic / Med+) — WeightWatchers (2026)
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration (2025)
- WeightWatchers GLP-1 Weight Loss Program Review — U.S. News & World Report (2026)